PGHL

Procter & Gamble Health Share PriceProcter & Gamble Health

₹4901.25
15 (0.31%)
  • Advice
  • Hold
As on 24 March, 2023 | 18:50 BSE: 500126 NSE: PGHL

Procter & Gamble Health Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Procter & Gamble Health

Start SIP

Procter & Gamble Health Share Price

  • Over 1 Month 4.75%
  • Over 3 Month 20.64%
  • Over 6 Month 19.71%
  • Over 1 Year 14.89%

Procter & Gamble Health Key Statistics

P/E Ratio 34.9
PEG Ratio 0.6
Market Cap Cr 8,136
Price to Book Ratio 13.2
EPS 116.2
Dividend 2
Relative Strength Index 56.21
Money Flow Index 67.66
MACD Signal 114.06
Average True Range 154.65

Procter & Gamble Health Investment Rating

  • Master Rating:
  • Procter & Gamble Health has an operating revenue of Rs. 1,171.23 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 23% is great, ROE of 31% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 14% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Procter & Gamble Health Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 310298296268
Operating Expenses Qtr Cr 200207236199
Operating Profit Qtr Cr 110915969
Depreciation Qtr Cr 10776
Interest Qtr Cr 0000
Tax Qtr Cr 28231314
Net Profit Qtr Cr 77644151

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹4901.25
15 (0.31%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • 4860.32
  • 50 Day
  • 4653.91
  • 100 Day
  • 4478.45
  • 200 Day
  • 4435.93
  • 20 Day
  • 4917.28
  • 50 Day
  • 4572.43
  • 100 Day
  • 4357.04
  • 200 Day
  • 4283.69

Procter & Gamble Health Resistance and Support

PIVOT
₹4914.94
Resistance
First Resistance 4949.97
Second Resistance 5013.69
Third Resistance 5048.72
RSI 56.21
MFI 67.66
MACD Single Line 114.06
MACD 81.96
Support
First Resistance 4851.22
Second Resistance 4816.19
Third Resistance 4752.47

Procter & Gamble Health Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 25,773 1,113,651 43.21
Week 10,247 504,572 49.24
1 Month 17,515 766,292 43.75
6 Month 10,282 563,343 54.79

Procter & Gamble Health Result Highlights

Procter & Gamble Health Synopsis

NSE-Medical-Generic Drugs

P&G Health is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 1114.41 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 30/06/2022. Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726.
Market Cap 8,138
Sales 1,171
Shares in Float 0.80
No of funds 121
Yield 2
Book Value 13.16
U/D Vol ratio 2.6
LTDebt / Equity
Alpha 0.07
Beta 0.48

Procter & Gamble Health

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 51.82%51.82%51.82%
Mutual Funds 7.28%6.9%6.61%
Insurance Companies 5.11%5.66%1.46%
Foreign Portfolio Investors 6.33%6.05%6.47%
Financial Institutions/ Banks
Individual Investors 24.32%24.46%25.09%
Others 5.14%5.11%8.55%

Procter & Gamble Health Management

Name Designation
Mr. Suresh Talwar Chairman & Ind.Director
Mr. Milind Thatte Managing Director
Mr. Amit Gupta Executive Director & CFO
Mr. Aalok Agrawal Non Executive Director
Dr. Elizabeth Desmond Non Executive Director
Mrs. Rani Jadhav Independent Director
Mr. S Madhavan Independent Director

Procter & Gamble Health Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Procter & Gamble Health MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
HDFC Small Cap Fund Growth 14649
UTI MNC Fund Regular Plan Growth 2366
Tata Flexi Cap Fund Regular Growth 2096
Sundaram Small Cap Fund - Regular Plan - Growth Option 1962

Procter & Gamble Health FAQs

What is Share Price of Procter & Gamble Health ?

Procter & Gamble Health share price is ₹4901 As on 24 March, 2023 | 18:36

What is the Market Cap of Procter & Gamble Health ?

The Market Cap of Procter & Gamble Health is ₹8135.8 Cr As on 24 March, 2023 | 18:36

What is the P/E ratio of Procter & Gamble Health ?

The P/E ratio of Procter & Gamble Health is 34.9 As on 24 March, 2023 | 18:36

What is the PB ratio of Procter & Gamble Health ?

The PB ratio of Procter & Gamble Health is 13.2 As on 24 March, 2023 | 18:36

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number